NFKB1 and osteoarthritis: Fu et al. documented the potential of UA as a therapeutic agent for osteoarthritis, considering that it could effectively inhibit IL-1β-induced activation of the PI3K/Akt/NF-κB pathway, thereby reducing inflammation and catabolic processes in osteoarthritic chondrocytes [38].